Olav Larsen

1.4k total citations · 1 hit paper
27 papers, 1.1k citations indexed

About

Olav Larsen is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Olav Larsen has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Olav Larsen's work include Chemokine receptors and signaling (15 papers), Receptor Mechanisms and Signaling (10 papers) and T-cell and B-cell Immunology (6 papers). Olav Larsen is often cited by papers focused on Chemokine receptors and signaling (15 papers), Receptor Mechanisms and Signaling (10 papers) and T-cell and B-cell Immunology (6 papers). Olav Larsen collaborates with scholars based in Denmark, United States and Belgium. Olav Larsen's co-authors include Mette M. Rosenkilde, Jens J. Holst, Anne Steen, C. Christiansen, Berit Svendsen, Daniel J. Drucker, M Gabe, Stefanie Thiele, Gertrud M. Hjortø and Bolette Hartmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Olav Larsen

27 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin Secretion Depends on Intra-islet Glucagon Signaling

2018 258 citations Berit Svendsen, Olav Larsen et al. Cell Reports profile →

Peers

Olav Larsen

ONCOL

SURGE

EDM

IMMUN

Christer Ericsson Sweden

Klara R. Klein United States

Rive Sarfstein Israel

D Flavell United Kingdom

E. P. Slater Germany

Marie‐Thérèse Groyer‐Picard France

C L Hsieh United States

Silvia Cantara Italy

Rosemary Foley United Kingdom

Paul Rava United States

Christer Ericsson Sweden

Olav Larsen

600 ×1.5

141 ×0.4

ONCOL

323 ×1.0

SURGE

234 ×0.7

EDM

180 ×0.6

IMMUN

Citations per year, relative to Olav Larsen Olav Larsen (= 1×) peers Christer Ericsson

Countries citing papers authored by Olav Larsen

Since Specialization

Citations

This map shows the geographic impact of Olav Larsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olav Larsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olav Larsen more than expected).

Fields of papers citing papers by Olav Larsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olav Larsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olav Larsen. The network helps show where Olav Larsen may publish in the future.

Co-authorship network of co-authors of Olav Larsen

This figure shows the co-authorship network connecting the top 25 collaborators of Olav Larsen. A scholar is included among the top collaborators of Olav Larsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olav Larsen. Olav Larsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Larsen, Olav, et al.. (2023). Chemokine N‐terminal‐derived peptides differentially regulate signaling by the receptors CCR1 and CCR5. FEBS Letters. 597(24). 3049–3060. 1 indexed citations

Lindqvist, Andreas, Mia Abels, Liliya Shcherbina, et al.. (2023). GPR162 is a beta cell CART receptor. iScience. 26(12). 108416–108416. 1 indexed citations

Larsen, Olav, Wijnand J. C. van der Velden, Martin Gustavsson, et al.. (2022). Identification of a conserved chemokine receptor motif that enables ligand discrimination. Science Signaling. 15(724). eabg7042–eabg7042. 3 indexed citations

Velden, Wijnand J. C. van der, C. Christiansen, Thor C. Møller, et al.. (2021). GLP-1 Val8: A Biased GLP-1R Agonist with Altered Binding Kinetics and Impaired Release of Pancreatic Hormones in Rats. ACS Pharmacology & Translational Science. 4(1). 296–313. 23 indexed citations

Larsen, Olav, Edith Uetz‐von Allmen, Michael Lückmann, et al.. (2019). Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7. Frontiers in Immunology. 10. 2156–2156. 16 indexed citations

Thomas, Monica A., Acacia F. Dishman, Olav Larsen, et al.. (2019). Structure-function guided modeling of chemokine-GPCR specificity for the chemokine XCL1 and its receptor XCR1. Science Signaling. 12(597). 18 indexed citations

Kuhre, Rune E., Nicolai J. Wewer Albrechtsen, Olav Larsen, et al.. (2018). Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas. Molecular Metabolism. 11. 84–95. 178 indexed citations

Janssens, Rik, Daiane Boff, Pieter Ruytinx, et al.. (2018). Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation in vivo and Anti-HIV-1 Activity. Frontiers in Immunology. 9. 1933–1933. 6 indexed citations

Svendsen, Berit, Olav Larsen, M Gabe, et al.. (2018). Insulin Secretion Depends on Intra-islet Glucagon Signaling. Cell Reports. 25(5). 1127–1134.e2. 258 indexed citations breakdown →

10.

Ritter, Birgit, Kai A. Kropp, Verónica Durán, et al.. (2017). Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration. PLoS Pathogens. 13(5). e1006346–e1006346. 17 indexed citations

11.

Janssens, Rik, Anneleen Mortier, Daiane Boff, et al.. (2017). Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes. Biochemical Pharmacology. 132. 92–101. 39 indexed citations

12.

Hjortø, Gertrud M., Olav Larsen, Anne Steen, et al.. (2016). Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines. Frontiers in Immunology. 7. 568–568. 59 indexed citations

13.

Larsen, Olav, Anne Steen, Matjaž Brvar, et al.. (2016). Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5). Journal of Biological Chemistry. 291(52). 26860–26874. 12 indexed citations

14.

Larsen, Olav, M. Hauge, Robert M. Jones, et al.. (2016). Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119. Biochemical Pharmacology. 119. 66–75. 45 indexed citations

15.

Larsen, Olav, et al.. (2016). Attenuation of chemokine receptor function and surface expression as an immunomodulatory strategy employed by human cytomegalovirus is linked to vGPCR US28. Cell Communication and Signaling. 14(1). 31–31. 11 indexed citations

16.

Lückmann, Michael, et al.. (2016). Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding. Journal of Biological Chemistry. 291(31). 16208–16220. 10 indexed citations

17.

Palmisano, Ralf, Reiner Waibel, Jürgen Einsiedel, et al.. (2016). Discovery and Characterization of Biased Allosteric Agonists of the Chemokine Receptor CXCR3. Journal of Medicinal Chemistry. 59(5). 2222–2243. 20 indexed citations

18.

Steen, Anne, Olav Larsen, Stefanie Thiele, & Mette M. Rosenkilde. (2014). Biased and G Protein-Independent Signaling of Chemokine Receptors. Frontiers in Immunology. 5. 277–277. 144 indexed citations

19.

Jensen, Hanna, et al.. (2008). Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer. British Journal of Cancer. 99(6). 858–861. 12 indexed citations

20.

Bailey, J.C., et al.. (1987). Strontium isotope variations in lower tertiary-quaternary volcanic rocks from the Kurile island arc. Contributions to Mineralogy and Petrology. 95(2). 155–165. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact